Biogen Idec Lays Off 13 Percent of Staff, Retrenches Around Multiple Sclerosis
The restructuring leaves oncology and IDEC behind and reemphasizes the "Biogen" in Biogen Idec.
The restructuring leaves oncology and IDEC behind and reemphasizes the "Biogen" in Biogen Idec.